Levetiracetam | Bluepoint Laboratories Breastfeeding

American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Levetiracetam | Bluepoint Laboratories for its safety in breastfeeding.

What is Levetiracetam | Bluepoint Laboratories used for?


Levetiracetam is indicated for adjunctive therapy in the treatment of: •Partial onset seizures in patients one month of age and older with epilepsy (1.1) •Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) •Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3) 1.1 Partial Onset Seizures Levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam tablets are indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam tablets are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy.

What are the risk associated with Levetiracetam | Bluepoint Laboratories usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Levetiracetam | Bluepoint Laboratories safe for breastfeeding
As per our analysis Levetiracetam | Bluepoint Laboratories contains only one ingredient and that is Levetiracetam. We have analyzed Levetiracetam and it seems to be safe to use Levetiracetam while breastfeeding, that means usage of Levetiracetam | Bluepoint Laboratories shall be safe while breastfeeding. Below you can check more details of Levetiracetam usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Levetiracetam is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from levetiracetam, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Levetiracetam | Bluepoint Laboratories Breastfeeding Analsys


Levetiracetam while Breastfeeding

Safe

CAS Number: 102767-28-2

Piracetam analog with nootropic and anti-epileptic effect. Authorized for use in children in Europe. Excreted into breast milk but infant serum levels were shown to be low. No other side effect than one case of hypotonia in a 7 days old premature whose mother was also on anti-epileptic medication. Seizures along with neonatal abstinence syndrome in a botlle fed neonate whose mother had taken Levetiracetam and Phenobarbital in pregnancy ocurred. Symptoms disappeared after initiation of breastfeeding.


Levetiracetam | Bluepoint Laboratories Breastfeeding Analsys - 2


Levetiracetam while Breastfeeding

CAS Number: 102767-28-2

Maternal doses of levetiracetam up to 3500 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. If levetiracetam is required by the mother, it is not a reason to discontinue breastfeeding. However, the infant should be monitored for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Maternal serum level monitoring and dosage adjustment is advisable in the early postpartum period if the drug was taken throughout pregnancy and breastfeeding.[1] Some evidence suggests that levetiracetam might reduce the maternal breastmilk supply in some women.


Levetiracetam | Bluepoint Laboratories and breastfeeding

I already used Levetiracetam | Bluepoint Laboratories and meanwhile I breastfed my baby should I be concerned?

Levetiracetam | Bluepoint Laboratories is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Levetiracetam | Bluepoint Laboratories you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


I am nursing mother and my doctor has suggested me to use Levetiracetam | Bluepoint Laboratories, is it safe?

Definitely, Levetiracetam | Bluepoint Laboratories is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Levetiracetam | Bluepoint Laboratories, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Levetiracetam | Bluepoint Laboratories


Who can I talk to if I have questions about usage of Levetiracetam | Bluepoint Laboratories in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week